References
- Chen C, Xia HS, Gong YP, et al (2010). The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials, 31, 8818-25. https://doi.org/10.1016/j.biomaterials.2010.07.091
- Cianfrocca M, Gradishar W (2009). New molecular classifications of breast cancer. CA Cancer J Clin, 59, 303-13. https://doi.org/10.3322/caac.20029
- Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr (2010). Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. J Am Coll Surg, 210, 797-805.e1, 805-7. https://doi.org/10.1016/j.jamcollsurg.2010.02.045
- der Wal BC v, Butzelaar RM, der Meij S v, Boermeester MA (2002). Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol, 28, 481-9. https://doi.org/10.1053/ejso.2002.1239
- Duraker N, Bati B, Demir D, Caynak ZC (2011). Prognostic significance of the number of removed and metastatic lymph nodes and lymph node ratio in breast carcinoma patients with 1-3 axillary lymph node(s) metastasis. ISRN Oncol, 2011, 645450.
- Fan L, Zheng Y, Yu KD, et al (2009). Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat, 117, 409-16. https://doi.org/10.1007/s10549-008-0303-z
- Goldhirsch A, Ingle JN, Gelber RD, et al (2009). Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol, 20, 1319-29. https://doi.org/10.1093/annonc/mdp322
- Han TJ, Kang EY, Jeon W, et al (2011). The prognostic value of the nodal ratio in N1 breast cancer. Radiat Oncol, 6, 131. https://doi.org/10.1186/1748-717X-6-131
- Harper S, Lynch J, Meersman SC, et al (2009). Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev, 18, 121-31. https://doi.org/10.1158/1055-9965.EPI-08-0679
- Hatoum HA, Jamali FR, El-Saghir NS, et al (2009). Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Ann Surg Oncol, 16, 3388-95. https://doi.org/10.1245/s10434-009-0653-8
- Ibrahim EM, Elkhodary TR, Zekri JM, et al (2010). Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia. Asia Pac J Clin Oncol, 6, 130-7. https://doi.org/10.1111/j.1743-7563.2010.01288.x
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49. https://doi.org/10.3322/caac.20006
- Karihtala P, Winqvist R, Bloigu R, Jukkola-Vuorinen A (2010). Long-term observational follow-up study of breast cancer diagnosed in women =40 years old. Breast, 19, 456-61. https://doi.org/10.1016/j.breast.2010.05.001
- Kim JY, Ryu MR, Choi BO, et al. (2011).The prognostic significance of the lymph node ratio in axillary lymph node positive breast cancer. J Breast Cancer, 14, 204-12. https://doi.org/10.4048/jbc.2011.14.3.204
- Mersin H, Yildirim E, Berberoglu U, Gulben K (2009). Triple negative phenotype and N-ratio are important for prognosis in patients with stage IIIB non-inflammatory breast carcinoma. J Surg Oncol, 100, 681-7. https://doi.org/10.1002/jso.21411
- Overman MJ, Hu CY, Wolff RA, Chang GJ (2010). Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer, 116, 5374-82. https://doi.org/10.1002/cncr.25324
- Pedraza AM, Pollan M, Pastor-Barriuso R, Cabanes A (2012). Disparities in breast cancer mortality trends in a middle income country. Breast Cancer Res Treat, 134, 1199-207. https://doi.org/10.1007/s10549-012-2026-4
- Schiffman SC, McMasters KM, Scoggins CR, Martin RC, Chagpar AB (2011). Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. J Am Coll Surg, 213, 45-52; discussion 52-3. https://doi.org/10.1016/j.jamcollsurg.2011.04.024
- Schmoor C, Sauerbrei W, Bastert G, Bojar H, Schumacher M (2001). Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF. Eur J Cancer, 37, 1123-31. https://doi.org/10.1016/S0959-8049(01)00090-9
- Schootman M, Lian M, Deshpande AD, et al (2010). Temporal trends in area socioeconomic disparities in breast-cancer incidence and mortality, 1988-2005. Breast Cancer Res Treat, 122, 533-43. https://doi.org/10.1007/s10549-009-0729-y
- Singletary SE, Allred C, Ashley P, et al (2002). Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol, 20, 3628-36. https://doi.org/10.1200/JCO.2002.02.026
- Singletary SE, Connolly JL (2006). Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin, 56, 37-47; quiz 50-1. https://doi.org/10.3322/canjclin.56.1.37
- Sotiriou C, Pusztai L (2009). Gene-expression signatures in breast cancer. N Engl J Med, 360, 790-800. https://doi.org/10.1056/NEJMra0801289
- Tausch C, Taucher S, Dubsky P, et al (2012). Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG). Ann Surg Oncol, 19, 1808-17. https://doi.org/10.1245/s10434-011-2189-y
- Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA (2005). The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer, 103, 2006-14. https://doi.org/10.1002/cncr.20969
- Veronesi U, Zurrida S, Viale G, et al (2009). Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research. Breast J, 15, 291-5. https://doi.org/10.1111/j.1524-4741.2009.00719.x
- Vinh-Hung V, Joseph SA, Coutty N, et al (2010). Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer. Oncologis, 15, 1050-62. https://doi.org/10.1634/theoncologist.2010-0044
- Vinh-Hung V, Verkooijen HM, Fioretta G, et al (2009). Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol, 27, 1062-8. https://doi.org/10.1200/JCO.2008.18.6965
- Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G (2004). The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol, 70, 225-30. https://doi.org/10.1016/j.radonc.2003.10.015
- Weigelt B, Baehner FL, Reis-Filho JS (2010). The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol, 220, 263-80.
Cited by
- Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio vol.21, pp.5, 2016, https://doi.org/10.1007/s10147-016-0956-2
- Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy pp.1573-7217, 2018, https://doi.org/10.1007/s10549-018-4966-9